Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 12Prostatic Neoplasms 9Head and Neck Neoplasms 9Brain Neoplasms 6Uterine Cervical Neoplasms 4Tongue Neoplasms 4Central Nervous System Neoplasms 4Papillomavirus Infections 3Radiation Injuries 2Precancerous Conditions 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Neurotoxicity Syndromes 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Endometrial Neoplasms 2Carcinoma 2Astrocytoma 2Anus Neoplasms 2Anal Canal Carcinoma 2Vulvar Neoplasms 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Salivary Gland Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Obesity 1Neuroblastoma 1Neoplasms 1

Interventions

Gemcitabine 3Capecitabine 3Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Ondansetron 1Fluorouracil 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Bile Duct Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT00789958 2018-04-09

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

SWOG Cancer Research Network

Phase 2 Completed
105 enrolled 13 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡